This product is a Chimeric (mouse/human) antibody that recognizes MARCO.
Figure 1 The superiority of CD40 over eight other receptors for CD8+ T cell crosspriming.
Yin, W. (2015). Dendritic Cell Targeting Vaccines for HPV-Associated Malignancies and Prostate Cancer (Doctoral dissertation, Baylor University).
Figure 2 Targeting antigen to DCs via CD40 can efficiently prime CD8+ CTLs.
Yin, W. (2015). Dendritic Cell Targeting Vaccines for HPV-Associated Malignancies and Prostate Cancer (Doctoral dissertation, Baylor University).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0025-FY | Mouse Anti-MARCO Recombinant Antibody (clone PLK-1) | FC, FuncS, IF, IP, WB | Mouse IgG3 |
There are currently no Customer reviews or questions for HPAB-A1260-YJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.